• Publications
  • Influence
Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases.
OBJECTIVE There is a need for clearly defined and widely applicable clinical criteria for the selection of patients who may benefit from hepatic resection for metastatic colorectal cancer. SuchExpand
  • 3,056
  • 169
Staging, Resectability, and Outcome in 225 Patients With Hilar Cholangiocarcinoma
ObjectiveTo analyze resectability and survival in patients with hilar cholangiocarcinoma according to a proposed preoperative staging scheme that fully integrates local, tumor-related factors.Expand
  • 1,031
  • 58
  • PDF
Improvement in Perioperative Outcome After Hepatic Resection: Analysis of 1,803 Consecutive Cases Over the Past Decade
ObjectiveTo assess the nature of changes in the field of hepatic resectional surgery and their impact on perioperative outcome. MethodsDemographics, extent of resection, concomitant major procedures,Expand
  • 1,219
  • 38
Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer.
BACKGROUND Two years after undergoing resection of liver metastases from colorectal cancer, about 65 percent of patients are alive and 25 percent are free of detectable disease. We tried to improveExpand
  • 825
  • 34
Intrahepatic Cholangiocarcinoma: Rising Frequency, Improved Survival, and Determinants of Outcome After Resection
Background:Despite data suggesting a rising worldwide incidence, intrahepatic cholangiocarcinoma (IHC) remains an uncommon disease. This study analyzes changes in IHC frequency, demographics, andExpand
  • 552
  • 34
  • PDF
Combined hepatocellular and cholangiocarcinoma
Tumors with combined hepatocellular and cholangiocellular features are well known histopathologically but their clinical behavior is poorly understood. The objectives of the current study were toExpand
  • 221
  • 27
Actual 10-year survival after resection of colorectal liver metastases defines cure.
PURPOSE Resection of colorectal liver metastases (CLM) in selected patients has evolved as the standard of care during the last 20 years. In the absence of prospective randomized clinical trials, aExpand
  • 858
  • 26
Hepatic neuroendocrine metastases: does intervention alter outcomes?
BACKGROUND In most instances, advanced neuroendocrine tumors follow an indolent course. Hepatic metastases are common, and although they can cause significant pain, incapacitating endocrinopathy, andExpand
  • 552
  • 25
Long-term results after resection for gallbladder cancer. Implications for staging and management.
BACKGROUND The surgical management of gallbladder cancer is controversial. There is no consensus among surgeons as to the indications for reoperation or radical resection. OBJECTIVE The purpose ofExpand
  • 351
  • 18
Gallbladder cancer (GBC): 10‐year experience at Memorial Sloan‐Kettering Cancer Centre (MSKCC)
The incidence of gallbladder cancer (GBC) in the US is 1.2/100,000. This report examines the patterns of presentation, adjuvant treatment and survival of a large cohort of patients with GBC evaluatedExpand
  • 281
  • 18
...
1
2
3
4
5
...